For: | Rao P, Koshy A, Philip J, Premaletha N, Varghese J, Narayanasamy K, Mohindra S, Pai NV, Agarwal MK, Konar A, Vora HB. Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C. World J Hepatol 2014; 6(7): 520-526 [PMID: 25068004 DOI: 10.4254/wjh.v6.i7.520] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v6/i7/520.htm |
Number | Citing Articles |
1 |
Brittany E Yee, Nghia H Nguyen, Bing Zhang, Derek Lin, Philip Vutien, Carrie R Wong, Glen A Lutchman, Mindie H Nguyen. Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. BMJ Open Gastroenterology 2015; 2(1): e000049 doi: 10.1136/bmjgast-2015-000049
|
2 |
Varun Gupta, Ashish Kumar, Praveen Sharma, Naresh Bansal, Vikas Singla, Anil Arora. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center. Journal of Clinical and Experimental Hepatology 2015; 5(2): 134 doi: 10.1016/j.jceh.2015.05.001
|
3 |
Soham Das, Diptangshu Sen, Varun Ramamohan, Ajit Sood. An Agent-Based Model of Hepatitis C Virus Transmission Dynamics in India. 2019 Winter Simulation Conference (WSC) 2019; : 984 doi: 10.1109/WSC40007.2019.9004857
|
4 |
Iwona Mozer-Lisewska, Katarzyna Zwolińska, Arleta Elżbieta Kowala-Piaskowska, Maciej Bura, Błażej Rozpłochowski, Anna Pauli, Jan Żeromski, Egbert Piasecki, Piotr Kuśnierczyk. Genetic (KIR, HLA-C) and Some Clinical Parameters Influencing the Level of Liver Enzymes and Early Virologic Response in Patients with Chronic Hepatitis C. Archivum Immunologiae et Therapiae Experimentalis 2016; 64(1): 65 doi: 10.1007/s00005-015-0350-1
|
5 |
Haohui Deng, Fengxia Guo, Weihua Yu, Linghua Li, Yang Xia, Yujuan Guan, Jianping Li. Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients. Virus Research 2021; 302: 198453 doi: 10.1016/j.virusres.2021.198453
|